Sanofi to Invest EUR350 Million in Canadian Vaccine Facility
April 12 2018 - 1:44AM
Dow Jones News
By Marc Navarro Gonzalez
Sanofi SA (SAN.FR) said Thursday that it is investing 350
million euros ($432.9 million) for the construction of a vaccine
manufacturing facility in Canada.
The investment will increase its capacity to meet growing demand
for pediatric and booster vaccines, the company said.
The facility will produce the antigens used in the diphtheria
and tetanus vaccines, it said.
The building will be located at the Sanofi Pasteur Canadian
headquarters in Toronto and construction will be completed in 2021,
the company said.
Write to Marc Navarro Gonzalez at marc.navarro@dowjones.com
(END) Dow Jones Newswires
April 12, 2018 01:29 ET (05:29 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Apr 2023 to Apr 2024
